Cell therapy for knee cartilage damage did not meet primary endpoint in phase 3 trial https://t.co/t6CwP5oMtu — Marisa Peer (@PeerMarisa) September 26, 2018
Cell therapy for knee cartilage damage did not meet primary endpoint in phase 3 trial https://t.co/t6CwP5oMtu
No comments:
Post a Comment